For instance, in renal cell carcinoma, fluvastatin inhibits the kinase p70S6Kα, accompanied by an increase in the expression of PDCD4 [65] and the formation of the eIF4E-binding protein-eIF4E complex, inducing apoptosis. Here, RPS6KB1 is linked to hereditary clear cell renal cell carcinoma.